The nitrate ingested over the course of a person’s adult lifetime through the consumption of tap water and bottled water could be a risk factor for prostate cancer, particularly in the case of ag...
Read moreScientists from the Oncology area of the Biosanitary Research Institute of Granada relate exposure to Bisphenol A with an increased risk of developing prostate cancer
Read morePARP inhibitors (PARPi) are approved for treating advanced prostate cancers with various defective DNA repair genes, although not all patients derive the same benefit from this targeted therapy.
Read moreOne in eight men will be diagnosed with prostate cancer at some point in their lifetime. Several treatments for this type of cancer are currently available, but the tumour develops resistance and the ...
Read moreResearchers of the Human Molecular Genetics group at the Bellvitge Biomedical Research Institute (IDIBELL), led by Dr. Sara Larriba, in collaboration with Dr. Francesc Vigués and Dr. Manel Castells o...
Read morePublished this month in the International Journal of Radiation Oncology, Biology, Physics*, findings first authored by Joan Carles, Principal Investigator of VHIO’s Genitourinary, CNS Tumors, Sar...
Read morePublished in the Journal of Clinical Oncology, the study has potential implications for families with members suffering from these two types of tumours who are at an increased risk of developing cance...
Read moreUS$2 million of DoD funding to support a project counting on the multidisciplinary expertise of researchers and physician scientists at VHIO, the Spanish National Cancer Research Centre and the Univer...
Read moreA study led by Dr. Rosanna Paciucci, principal investigator of the Biomedical Research Group in Urology of the Vall d'Hebron Research Institute (VHIR), points to the PTOV1 protein as a potential new t...
Read moreA team led by researchers of the Institute of Biomedicine of the University of Barcelona (IBUB) and the Research Institute of the Hospital de la Santa Creu i Sant Pau (IIB Sant Pau) shows for the fi...
Read moreThe expression of a central regulator of cell metabolism, PGC1A is associated with prostate cancer aggressiveness. The research paves the way for the identification of patients at risk of developing m...
Read moreThe detection of TMPRSS2-ERG in the blood of patients with resistant metastatic prostate cancer predicts resistance to taxanes, such as docetaxel, and may be useful for selecting the best treatment op...
Read more